Kurtis Eisermann
Biography
Dr. Eisermann is an Assistant Professor of Biological Sciences at Kent State Tuscarawas. He graduated with his PhD in Biomedical Sciences from Kent State University and then went on to do postdoctoral research at the University of Pittsburgh as an NIH Postdoctoral Scholar. He has published 14 peer reviewed journal articles in research focused on androgen regulation of prostate cancer and has identified small molecules to treat patients with castration resistant prostate cancer. Dr. Eisermann has taught for the past 10 years developing courses that encourage students to think more in depth about the concepts they are learning and he is always interested in learning new ways to challenge his students to help them reach their potential and achieve their goals. He was a Teaching Scholar through the Center for Teaching and Learning where he was trained on the Scholarship of Teaching and Learning (SoTL) and is currently researching allied health student motivation post-COVID in hybrid learning environments. In addition to teaching and research, Dr. Eisermann is a member of the Community Engagement Committee and has started a Biology/Premed Club at the Kent State Tuscarawas campus. In his free time, he likes to travel, spend time with family, play tennis, watch sports, and fix things around the house.
COURSES TAUGHT
- Elements of Genetics
- Human Genetics
- Biological Foundations
- Biological Diversity
- Foundational Anatomy and Physiology I
- Foundational Anatomy and Physiology II
- Anatomy for Veterinary Technicians
- Human Biology
- Life on Planet Earth
- Lab Experience in Biology
Education
MS, Immunology, Youngstown State University, 2006
BA, Biological Sciences, Kent State University, 2003
Expertise
hybrid
flipped
hyflex
and online. Research: Cancer genetics
Publications
- Eisermann, K. and Gerbig, D. Exploring Motivation of Allied Health Students in a Hybrid Learning Environment. 2024. Manuscript in preparation.
- Eisermann, K. and Fraizer, G.C. The androgen receptor and VEGF: mechanisms of androgen regulated angiogenesis in prostate cancer. Cancers. (Basel). 2017 Apr 10;9(4). pii: E32. doi: 10.3390/cancers9040032.
- Masoodi, K.Z., Eisermann, K. (co-first author), and Wang, Z. Inhibition of androgen receptor function and level in castration-resistant prostate cancer cells by 2-((isoxazol-4-ylmethyl)thio)-1-(4-phenylpiperazin-1-yl)ethanone. Endocrinology. 2017 July 24.
- Masoodi, K.Z., Xu, Y., Dar, J.A., Eisermann, K., Nelson, J.B., Wipf, P., and Wang, Z. Inhibition of Androgen Receptor Nuclear Localization and Castration Resistant Prostate Tumor Growth by Pyrroloimidazole-Based Small Molecules. Mol Cancer Ther. 2017 Jun
- Johnson, J. K., Skoda, E. M., Eisermann, K., Nelson, J. B., Wang, Z., and Wipf, P. Small Molecule Antagonists of the Nuclear Androgen Receptor for the Treatment of Castration-Resistant Prostate Cancer. ACS Medicinal Chemistry Letters. 2016 May
- Eisermann, K., Dar, J. A., Dong, J., Wang, D., Masoodi, K. Z., and Wang, Z. Poly (A) binding protein cytoplasmic 1 is a novel co-regulator of the androgen receptor. PLoS One. 2015 Jul 15; 10(7):e0128495. doi: 10.1371/journal.pone.0128495.
- O’Malley, K. J., Eisermann, K. (co-first author), Pascal, L. E., Nelson, J. B., Parwani, A., and Wang, Z. Proteomic analysis of patient tissue reveals PSA protein in the stroma of benign prostatic hyperplasia. The Prostate. 2014 Jun
- Eisermann, K., Wang, D., Jing, Y., Pascal, L. E., and Wang, Z. AR gene mutation, rearrangement, polymorphism. Trans Androl Urol, 2013 Sep 1; 2(3):137-147.
- Eisermann, K., Broderick, C. J., Bazarov, A., Moazam, M. M., and Fraizer, G. C. Androgen up-regulates vascular endothelial growth factor expression in prostate cancer cells via an Sp1 binding site. Molecular Cancer, 2013 Feb 1; 12:7. doi: 10.1186/1476-459
- Eisermann, K., Tandon, S., Bazarov, A., Brett, A., Fraizer, G., and Piontkivska, H. Evolutionary conservation of zinc finger transcription factor binding sites in promoters of genes co-expressed with WT1 in prostate cancer. BMC Genomics, 2008 Jul 16; 9:33